Ron Baron's position in Veracyte is currently worth $31M. That's 0.09% of their equity portfolio (154th largest holding). The first Veracyte trade was made in Q2 2019. Since then Ron Baron bought shares nine more times and sold shares on eight occasions. The stake costed the investor $19.5M, netting the investor a gain of 59% so far.